For: | Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343 [PMID: 37545640 DOI: 10.3748/wjg.v29.i27.4334] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm |
Number | Citing Articles |
1 |
Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao. Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1441785
|
2 |
|
3 |
Zong-Qiang Han, Li-Na Wen. Tofacitinib for ulcerative colitis: A promising treatment option. World Journal of Gastroenterology 2024; 30(40): 4386-4392 doi: 10.3748/wjg.v30.i40.4386
|
4 |
Gulshan Rathi, Prashant B. Shamkuwar, Karishma Rathi, Ruchita Ranazunjare, Soham Kulkarni. Contemporary and prospective use of azathioprine (AZA) in viral, rheumatic, and dermatological disorders: a review of pharmacogenomic and nanotechnology applications. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-03569-8
|